Tropoelastin turnover may be a new biomarker of dysfunctional matrix remodeling specifically present in aortic aneurysms and can be identified using a gadolinium-based tropoelastin-specific MR contrast agent (Gd-TESMA) in an animal model. This evidence concerns the gene ELN and aortic aneurysm.